Adverse results reported by Srivatsa et al. [12] showed that expression of Nm23 is strongly upregulated in most epithelial ovarian cancer and suggest that Nm23 gene expression may have distinct if not opposite biologic functions in epithelial ovarian cancer and breast carcinoma. This evidence concerns the gene NME1 and ovarian carcinoma.